Rotigotine - Restless Leg Syndrome
You are here : Home > Formulary Search > Rotigotine - Restless Leg Syndrome
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Patches
Formulary Status :
Restrictions / Comments :
Important
Preferred
Patients with severe symptoms, who are obese, co-morbid depression, increased risk of falls or cognitive impairment. Consider use of patch if significant daytime symptoms as it has a long duration of action.
Documentation
Evidence Review
PAD Profile
ChemicalSubstance :
Rotigotine
Indication :
Restless Leg Syndrome
Group Name :
Keywords :
dopamine receptor agonists
Brand Names Include :
Neupro
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Rotigotine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Restless Leg Syndrome.
Committee Recommendations (1)
Rotigotine is recommended as a FIRST line option for the treatment of Restless Leg Syndrome, as per CKS guidance.
Link to CKS page - https://cks.nice.org.uk/restless-legs-syndrome